Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Parkinson's Disease

Free Subscription Articles published in Arch Neurol Retrieve available abstracts of 75 articles: HTML format

Single Articles

April 2008
1. SCHWARZSCHILD MA , Schwid SR, Marek K, Watts A, et al
   Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease.
   Arch Neurol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. IKEUCHI T , Kakita A, Shiga A, Kasuga K, et al
   Patients Homozygous and Heterozygous for SNCA Duplication in a Family With Parkinsonism and Dementia.
   Arch Neurol. 2008;65:514-9.
   PubMed     Related articles    Abstract available
   
   
   
3. WANG Y , Clark LN, Louis ED, Mejia-Santana H, et al
   Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method.
   Arch Neurol. 2008;65:467-74.
   PubMed     Related articles    Abstract available
   
   
   
4. BOEVE BF , Hutton M
   Refining Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17: Introducing FTDP-17 (MAPT) and FTDP-17 (PGRN).
   Arch Neurol. 2008;65:460-4.
   PubMed     Related articles    Abstract available
   
   
   
5. KLEIN C , Ziegler A
   How to predict the risk of Parkinson disease in relatives of parkin mutation carriers: a complex puzzle of age, penetrance, and number of mutated alleles.
   Arch Neurol. 2008;65:443-4.
   PubMed     Related articles   
   
   
   February 2008
6. GUNZLER SA , Koudelka C, Carlson NE, Pavel M, et al
   Effect of low concentrations of apomorphine on parkinsonism in a randomized, placebo-controlled, crossover study.
   Arch Neurol. 2008;65:193-8.
   PubMed     Related articles    Abstract available
   
   
   
7. LOW HL , Sayer FT, Honey CR
   Pathological crying caused by high-frequency stimulation in the region of the caudal internal capsule.
   Arch Neurol. 2008;65:264-6.
   PubMed     Related articles    Abstract available
   
   
   December 2007
8. ROSENBERG R
   Notice of Redundant Publication: "Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease" (Arch Neurol. 2007;64[5]:676-682).
   Arch Neurol. 2007;64:1800-1.
   PubMed     Related articles   
   
   
   
9. CORVOL JC , Anzouan-Kacou JB, Fauveau E, Bonnet AM, et al
   Heart Valve Regurgitation, Pergolide Use, and Parkinson Disease: An Observational Study and Meta-analysis.
   Arch Neurol. 2007;64:1721-1726.
   PubMed     Related articles    Abstract available
   
   
   November 2007
10. LOUIS ED , Schupf N, Tang MX, Marder K, et al
    Mild parkinsonian signs and plasma homocysteine concentration in community-dwelling elderly individuals.
    Arch Neurol. 2007;64:1646-51.
    PubMed     Related articles    Abstract available
    
    
    
11. WALTER U , Dressler D, Probst T, Wolters A, et al
    Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Arch Neurol. 2007;64:1635-40.
    PubMed     Related articles    Abstract available
    
    
    
12. SPROULE DM , Kaufmann P, Engelstad K, Starc TJ, et al
    Wolff-Parkinson-White Syndrome in Patients With MELAS.
    Arch Neurol. 2007;64:1625-7.
    PubMed     Related articles    Abstract available
    
    
    October 2007
13. TAN EK
    Peripheral edema and dopamine agonists in Parkinson disease.
    Arch Neurol. 2007;64:1546-7.
    PubMed     Related articles   
    
    
    
14. PORYAZOVA R , Waldvogel D, Bassetti CL
    Sleepwalking in patients with Parkinson disease.
    Arch Neurol. 2007;64:1524-7.
    PubMed     Related articles    Abstract available
    
    
    
15. KIM JM , Hong S, Kim GP, Choi YJ, et al
    Importance of Low-Range CAG Expansion and CAA Interruption in SCA2 Parkinsonism.
    Arch Neurol. 2007;64:1510-8.
    PubMed     Related articles    Abstract available
    
    
    
16. ROCCA WA , Bower JH, Ahlskog JE, Elbaz A, et al
    Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease.
    Arch Neurol. 2007;64:1458-64.
    PubMed     Related articles    Abstract available
    
    
    
17. BROUWERS N , Nuytemans K, van der Zee J, Gijselinck I, et al
    Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.
    Arch Neurol. 2007;64:1436-46.
    PubMed     Related articles    Abstract available
    
    
    September 2007
18. LEVY G
    The relationship of Parkinson disease with aging.
    Arch Neurol. 2007;64:1242-6.
    PubMed     Related articles    Abstract available
    
    
    August 2007
19. VOON V , Fox SH
    Medication-related impulse control and repetitive behaviors in Parkinson disease.
    Arch Neurol. 2007;64:1089-96.
    PubMed     Related articles    Abstract available
    
    
    
20. SCHAPIRA AH
    Treatment options in the modern management of Parkinson disease.
    Arch Neurol. 2007;64:1083-8.
    PubMed     Related articles   
    
    
    July 2007
21. TAN EK , Tong J, Fook-Chong S, Yih Y, et al
    Glucocerebrosidase mutations and risk of Parkinson disease in chinese patients.
    Arch Neurol. 2007;64:1056-8.
    PubMed     Related articles   
    
    
    
22. KRAFF J , Tang HT, Cilia R, Canesi M, et al
    Screen for excess FMR1 premutation alleles among males with parkinsonism.
    Arch Neurol. 2007;64:1002-6.
    PubMed     Related articles    Abstract available
    
    
    
23. BALOH RH , Salavaggione E, Milbrandt J, Pestronk A, et al
    Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle.
    Arch Neurol. 2007;64:998-1000.
    PubMed     Related articles    Abstract available
    
    
    
24. RITZ B , Ascherio A, Checkoway H, Marder KS, et al
    Pooled analysis of tobacco use and risk of Parkinson disease.
    Arch Neurol. 2007;64:990-7.
    PubMed     Related articles    Abstract available
    
    
    
25. BOECKER H , Ceballos-Baumann AO, Volk D, Conrad B, et al
    Metabolic alterations in patients with Parkinson disease and visual hallucinations.
    Arch Neurol. 2007;64:984-8.
    PubMed     Related articles    Abstract available
    
    
    June 2007
26. DE BIE RM , Gladstone RM, Strafella AP, Ko JH, et al
    Manganese-induced parkinsonism associated with methcathinone (ephedrone) abuse.
    Arch Neurol. 2007;64:886-9.
    PubMed     Related articles    Abstract available
    
    
    
27. WAHNER AD , Sinsheimer JS, Bronstein JM, Ritz B, et al
    Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease.
    Arch Neurol. 2007;64:836-40.
    PubMed     Related articles    Abstract available
    
    
    
28. KLEINER-FISMAN G , Fisman DN
    Risk factors for the development of pedal edema in patients using pramipexole.
    Arch Neurol. 2007;64:820-4.
    PubMed     Related articles    Abstract available
    
    
    May 2007
29. STORCH A , Jost WH, Vieregge P, Spiegel J, et al
    Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease.
    Arch Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. JANKOVIC J , Watts RL, Martin W, Boroojerdi B, et al
    Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease.
    Arch Neurol. 2007;64:676-82.
    PubMed     Related articles    Abstract available
    
    
    April 2007
31. HANCOCK DB , Martin ER, Stajich JM, Jewett R, et al
    Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.
    Arch Neurol. 2007;64:576-80.
    PubMed     Related articles    Abstract available
    
    
    
32. HUDSON G , Schaefer AM, Taylor RW, Tiangyou W, et al
    Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism.
    Arch Neurol. 2007;64:553-7.
    PubMed     Related articles    Abstract available
    
    
    March 2007
33. LESAGE S , Janin S, Lohmann E, Leutenegger AL, et al
    LRRK2 Exon 41 Mutations in Sporadic Parkinson Disease in Europeans.
    Arch Neurol. 2007;64:425-30.
    PubMed     Related articles    Abstract available
    
    
    
34. DENG H , Le WD, Hunter CB, Mejia N, et al
    A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations.
    Arch Neurol. 2007;64:421-4.
    PubMed     Related articles    Abstract available
    
    
    
35. DEWEY RB JR , Reimold SC, O'suilleabhain PE
    Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.
    Arch Neurol. 2007;64:377-80.
    PubMed     Related articles    Abstract available
    
    
    
36. NUTT JG , Carter JH, Carlson NE
    Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Arch Neurol. 2007;64:319-23.
    PubMed     Related articles    Abstract available
    
    
    February 2007
37. JASINSKA-MYGA B , Opala G, Goetz CG, Tustanowski J, et al
    Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
    Arch Neurol. 2007;64:261-5.
    PubMed     Related articles    Abstract available
    
    
    
38. VOON V , Thomsen T, Miyasaki JM, de Souza M, et al
    Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.
    Arch Neurol. 2007;64:212-6.
    PubMed     Related articles    Abstract available
    
    
    January 2007
39. ROACH ES
    Both postsynaptic and presynaptic dysfunction contribute to Parkinson disease: any mechanism will not do.
    Arch Neurol. 2007;64:143.
    PubMed     Related articles   
    
    
    
40. DE LA FUENTE-FERNANDEZ R
    Presynaptic mechanisms of motor complications in Parkinson disease.
    Arch Neurol. 2007;64:141-3.
    PubMed     Related articles   
    
    
    
41. LINAZASORO G
    Pathophysiology of motor complications in Parkinson disease: postsynaptic mechanisms are crucial.
    Arch Neurol. 2007;64:137-40.
    PubMed     Related articles   
    
    
    December 2006
42. HAUSER RA , McDermott MP, Messing S
    Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.
    Arch Neurol. 2006;63:1756-60.
    PubMed     Related articles    Abstract available
    
    
    
43. TONG J , Hornykiewicz O, Kish SJ
    Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline.
    Arch Neurol. 2006;63:1724-8.
    PubMed     Related articles    Abstract available
    
    
    
44. HIDEYAMA T , Momose T, Shimizu J, Tsuji S, et al
    A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis.
    Arch Neurol. 2006;63:1719-22.
    PubMed     Related articles    Abstract available
    
    
    
45. AGGARWAL NT , Wilson RS, Beck TL, Bienias JL, et al
    Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease.
    Arch Neurol. 2006;63:1763-9.
    PubMed     Related articles    Abstract available
    
    
    October 2006
46. VAN HORN G , Schiess MC
    Benign tremulous parkinsonism?
    Arch Neurol. 2006;63:1507.
    PubMed     Related articles   
    
    
    
47. CHISHTI MA , Bohlega S, Ahmed M, Loualich A, et al
    T313M PINK1 Mutation in an Extended Highly Consanguineous Saudi Family With Early-Onset Parkinson Disease.
    Arch Neurol. 2006;63:1483-1485.
    PubMed     Related articles    Abstract available
    
    
    
48. JOSEPHS KA , Whitwell JL, Boeve BF, Knopman DS, et al
    Visual hallucinations in posterior cortical atrophy.
    Arch Neurol. 2006;63:1427-32.
    PubMed     Related articles    Abstract available
    
    
    September 2006
49. RUSSELL DS
    Benign tremulous parkinsonism.
    Arch Neurol. 2006;63:1346.
    PubMed     Related articles   
    
    
    
50. HAUGARVOLL K , Uitti RJ, Farrer MJ, Wszolek ZK, et al
    LRRK2 Gene and Tremor-Dominant Parkinsonism.
    Arch Neurol. 2006;63:1346-7.
    PubMed     Related articles   
    
    
    
51. FOX SH , Visanji NP, Johnston TH, Gomez-Ramirez J, et al
    Dopamine Receptor Agonists and Levodopa and Inducing Psychosis-Like Behavior in the MPTP Primate Model of Parkinson Disease.
    Arch Neurol. 2006;63:1343-4.
    PubMed     Related articles   
    
    
    
52. LEUTENEGGER AL , Salih MA, Ibanez P, Mukhtar MM, et al
    Juvenile-Onset Parkinsonism as a Result of the First Mutation in the Adenosine Triphosphate Orientation Domain of PINK1.
    Arch Neurol. 2006;63:1257-61.
    PubMed     Related articles    Abstract available
    
    
    
53. ISHIHARA L , Warren L, Gibson R, Amouri R, et al
    Clinical Features of Parkinson Disease Patients With Homozygous Leucine-Rich Repeat Kinase 2 G2019S Mutations.
    Arch Neurol. 2006;63:1250-4.
    PubMed     Related articles    Abstract available
    
    
    
54. TAN EK , Jankovic J
    Genetic testing in Parkinson disease: promises and pitfalls.
    Arch Neurol. 2006;63:1232-7.
    PubMed     Related articles   
    
    
    
55. SCHAPIRA AH
    The Importance of LRRK2 Mutations in Parkinson Disease.
    Arch Neurol. 2006;63:1225-8.
    PubMed     Related articles   
    
    
    
56. WOJTECKI L , Timmermann L, Jorgens S, Sudmeyer M, et al
    Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation.
    Arch Neurol. 2006;63:1273-6.
    PubMed     Related articles    Abstract available
    
    
    
57. PAPAPETROPOULOS S , Singer C, Ross OA, Toft M, et al
    Clinical heterogeneity of the LRRK2 G2019S mutation.
    Arch Neurol. 2006;63:1242-6.
    PubMed     Related articles    Abstract available
    
    
    
58. MORO E , Poon YY, Lozano AM, Saint-Cyr JA, et al
    Subthalamic nucleus stimulation: improvements in outcome with reprogramming.
    Arch Neurol. 2006;63:1266-72.
    PubMed     Related articles    Abstract available
    
    
    August 2006
59. CHUNG EJ , Ki CS, Lee WY, Kim IS, et al
    Clinical features and gene analysis in Korean patients with early-onset Parkinson disease.
    Arch Neurol. 2006;63:1170-4.
    PubMed     Related articles    Abstract available
    
    
    
60. HOUETO JL , Mallet L, Mesnage V, Tezenas du Montcel S, et al
    Subthalamic stimulation in Parkinson disease: behavior and social adaptation.
    Arch Neurol. 2006;63:1090-5.
    PubMed     Related articles    Abstract available
    
    
    
61. GRAFF-RADFORD J , Foote KD, Rodriguez RL, Fernandez HH, et al
    Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia.
    Arch Neurol. 2006;63:1181-4.
    PubMed     Related articles    Abstract available
    
    
    
62. JAIN S , Lo SE, Louis ED
    Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor?
    Arch Neurol. 2006;63:1100-4.
    PubMed     Related articles    Abstract available
    
    
    July 2006
63. WEINTRAUB D , Siderowf AD, Potenza MN, Goveas J, et al
    Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease.
    Arch Neurol. 2006;63:969-973.
    PubMed     Related articles    Abstract available
    
    
    
64. WIDER C , Russmann H, Villemure JG, Robert B, et al
    Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
    Arch Neurol. 2006;63:951-5.
    PubMed     Related articles    Abstract available
    
    
    June 2006
65. HEDRICH K , Hagenah J, Djarmati A, Hiller A, et al
    Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?
    Arch Neurol. 2006;63:833-8.
    PubMed     Related articles    Abstract available
    
    
    
66. SUN M , Latourelle JC, Wooten GF, Lew MF, et al
    Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.
    Arch Neurol. 2006;63:826-32.
    PubMed     Related articles    Abstract available
    
    
    
67. BEFFERT U , Rosenberg RN
    Increased risk for heterozygotes in recessive Parkinson disease.
    Arch Neurol. 2006;63:807-8.
    PubMed     Related articles   
    
    
    May 2006
68. ZHANG ZX , Dong ZH, Roman GC
    Early descriptions of Parkinson disease in ancient China.
    Arch Neurol. 2006;63:782-4.
    PubMed     Related articles   
    
    
    
69. OKUN MS , Fernandez HH, Rodriguez RL, Romrell J, et al
    Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Arch Neurol. 2006;63:729-35.
    PubMed     Related articles    Abstract available
    
    
    
70. LOUIS ED , Luchsinger JA
    History of vascular disease and mild parkinsonian signs in community-dwelling elderly individuals.
    Arch Neurol. 2006;63:717-22.
    PubMed     Related articles    Abstract available
    
    
    
71. GOETZ CG , Fan W, Leurgans S, Bernard B, et al
    The malignant course of "benign hallucinations" in Parkinson disease.
    Arch Neurol. 2006;63:713-6.
    PubMed     Related articles    Abstract available
    
    
    
72. MUQIT MM , Gandhi S, Wood NW
    Mitochondria in Parkinson disease: back in fashion with a little help from genetics.
    Arch Neurol. 2006;63:649-54.
    PubMed     Related articles    Abstract available
    
    
    April 2006
73. GREFFARD S , Verny M, Bonnet AM, Beinis JY, et al
    Motor Score of the Unified Parkinson Disease Rating Scale as a Good Predictor of Lewy Body-Associated Neuronal Loss in the Substantia Nigra.
    Arch Neurol. 2006;63:584-588.
    PubMed     Related articles    Abstract available
    
    
    
74. BABA Y , Markopoulou K, Putzke JD, Whaley NR, et al
    Phenotypic commonalities in familial and sporadic Parkinson disease.
    Arch Neurol. 2006;63:579-83.
    PubMed     Related articles    Abstract available
    
    
    
75. CLARK LN , Afridi S, Karlins E, Wang Y, et al
    Case-Control Study of the Parkin Gene in Early-Onset Parkinson Disease.
    Arch Neurol. 2006;63:548-552.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: